Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study by Li, X, Ostropolets, A, Makadia, R, Shoaibi, A, Rao, G, Sena, AG, Martinez-Hernandez, E, Delmestri, A, Verhamme, K, Rijnbeek, PR, Duarte-Salles, T, Suchard, MA, Ryan, PB, Hripcsak, G, Prieto-Alhambra, D

Bias, precision and timeliness of historical (background) rate comparison methods for vaccine safety monitoring: an empirical multi-database analysis by Li, X, Lai, LY, Ostropolets, A, Arshad, F, Tan, EH, Casajust, P, Alshammari, TM, Duarte-Salles, T, Minty, EP, Areia, C, Pratt, N, Ryan, PB, Hripcsak, G, Suchard, MA, Schuemie, MJ, Prieto-Alhambra, D

Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe by Morales, D, Ostropolets, A, Lai, L, Sena, A, Duvall, S, Suchard, M, Verhamme, K, Rjinbeek, P, Posada, J, Ahmed, W, Alshammary, T, Alghoul, H, Alser, O, Areia, C, Blacketer, C, Burn, E, Casajust, P, You, S, Dawoud, D, Golozar, A, Gong, M, Jonnagaddala, J, Lynch, K, Matheny, M, Minty, E, Nyberg, F, Uribe, A, Recalde, M, Reich, C, Scheumie, M, Shah, K, Shah, N, Schilling, L, Vizcaya, D, Zhang, L, Hripcsak, G, Ryan, P, Prieto-Alhambra, D, Durate-Salles, T, Kostka, K

COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries by Tan, EH, Sena, AG, Prats-Uribe, A, You, SC, Ahmed, W, Kostka, K, Reich, C, Duvall, SL, Lynch, KE, Matheny, ME, Duarte-Salles, T, Bertolin, SF, Hripcsak, G, Natarajan, K, Falconer, T, Spotnitz, M, Ostropolets, A, Blacketer, C, Alshammari, TM, Alghoul, H, Alser, O, Lane, JCE, Dawoud, DM, Shah, K, Yang, Y, Zhang, L, Areia, C, Golozar, A, Recalde, M, Casajust, P, Jonnagaddala, J, Subbian, V, Vizcaya, D, Lai, LYH, Nyberg, F, Morales, DR, Posada, JD, Shah, NH, Gong, M, Vivekanantham, A, Abend, A, Minty, EP, Suchard, M, Rijnbeek, P, Ryan, PB, Prieto-Alhambra, D

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort study by Lane, JCE, Weaver, J, Kostka, K, Duarte-Salles, T, Abrahao, MTF, Alghoul, H, Alser, O, Alshammari, TM, Areia, C, Biedermann, P, Banda, JM, Burn, E, Casajust, P, Fišer, K, Hardin, J, Hester, L, Hripcsak, G, Kaas-Hansen, BS, Khosla, S, Kolovos, S, Lynch, KE, Makadia, R, Mehta, PP, Morales, DR, Morgan-Stewart, H, Mosseveld, M, Newby, D, Nyberg, F, Ostropolets, A, Park, RW, Prats-Uribe, A, Rao, GA, Reich, C, Rijnbeek, P, Sena, AG, Shoaibi, A, Spotnitz, M, Subbian, V, Suchard, MA, Vizcaya, D, Wen, H, Wilde, MD, Xie, J, You, SC, Zhang, L, Lovestone, S, Ryan, P, Prieto Alhambra, D

Characteristics and outcomes of over 300,000 patients with COVID-19 and history of cancer in the United States and Spain by Roel, E, Pistillo, A, Recalde, M, Sena, AG, Fernández-Bertolín,, S, Aragón, M, Puente, D, Ahmed, W-U-R, Alghoul, H, Alser, O, Alshammari, TM, Areia, C, Blacketer, C, Carter, W, Casajust, P, Culhane, AC, Dawoud, D, DeFalco, F, DuVall, SL, Falconer, T, Asieh, G, Gong, M, Hester, L, Hripcsak, G, Tan, EH, Hokyun, J, Jonnagaddala, J, Lai, LYH, Lynch, KE, Matheny, ME, Morales, DR, Natarajan, K, Nyberg, F, Ostropolets, A, Posada, JD, Prats-Uribe, A, Reich, CG, Rivera, D, Schilling, LM, Soerjomataram, I, Shah, K, Shah, N, Shen, Y, Spotniz, M, Subbian, V, Suchard, MA, Trama, A, Zhang, L, Zhang, Y, Ryan, P, Prieto Alhambra, D

Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS by Kostka K, Duarte-Salles T, Prats-Uribe A, Sena AG, Pistillo A, Khalid S, Lai LYH, Golozar A, Alshammari TM, Dawoud DM, Nyberg F, Wilcox AB, Andryc A, Williams A, Ostropolets A, Areia C, Jung CY, Harle CA, Reich CG, Blacketer C, Morales DR, Dorr DA, Burn E, Roel E, Tan EH, Minty E, DeFalco F, de Maeztu G, Lipori G, Alghoul H, Zhu H, Thomas JA, Bian J, Park J, Martínez Roldán J, Posada JD, Banda JM, Horcajada JP, Kohler J, Shah K, Natarajan K, Lynch KE, Liu L, Schilling LM, Recalde M, Spotnitz M, Gong M, Matheny ME, Valveny N, Weiskopf NG, Shah N, Alser O, Casajust P, Park RW, Schuff R, Seager S, DuVall SL, You SC, Song S, Fernández-Bertolín S, Fortin S, Magoc T, Falconer T, Subbian V, Huser V, Ahmed WUR, Carter W, Guan Y, Galvan Y, He X, Rijnbeek PR, Hripcsak G, Ryan PB, Suchard MA, Prieto-Alhambra D

Get full text

Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS by Kostka, K, Duarte-Salles, T, Prats-Uribe, A, Sena, AG, Pistillo, A, Khalid, S, Lai, LYH, Golozar, A, Alshammari, TM, Dawoud, DM, Nyberg, F, Wilcox, AB, Andryc, A, Williams, A, Ostropolets, A, Areia, C, Jung, CY, Harle, CA, Reich, CG, Blacketer, C, Morales, DR, Dorr, DA, Burn, E, Roel, E, Tan, EH, Minty, E, DeFalco, F, de Maeztu, G, Lipori, G, Alghoul, H, Zhu, H, Thomas, JA, Bian, J, Park, J, Martínez Roldán, J, Posada, JD, Banda, JM, Horcajada, JP, Kohler, J, Shah, K, Natarajan, K, Lynch, KE, Liu, L, Schilling, LM, Recalde, M, Spotnitz, M, Gong, M, Matheny, ME, Valveny, N, Weiskopf, NG, Shah, N, Alser, O, Casajust, P, Park, RW, Schuff, R, Seager, S, DuVall, SL, You, SC, Song, S, Fernández-Bertolín, S, Fortin, S, Magoc, T, Falconer, T, Subbian, V, Huser, V, Ahmed, W-U-R, Carter, W, Guan, Y, Galvan, Y, He, X, Rijnbeek, PR, Hripcsak, G, Ryan, PB, Suchard, MA, Prieto-Alhambra, D